Policy suggestions for Medicare/Medicaid cost transparency and technology spending

Summary

Policy suggestions for Medicare/Medicaid cost transparency and technology spending The passage outlines generic healthcare policy ideas and mentions startups and think‑tank reports, but it does not identify specific powerful individuals, financial transactions, or actionable investigative leads. It offers low‑value context rather than a concrete lead. Key insights: Mentions Castlight Health and venture‑capital financing as a price‑transparency startup.; References Deloitte and Kaiser Family Foundation studies on cost‑benefit analysis.; Notes political sensitivity around rationing and market‑based approaches.